Cambridge hospital chooses supplier for PET study
LabLogic Systems have been chosen by the Department of Medical Physics and Clinical Engineering at Addenbroke's Hospital in Cambridge, UK to supply the equipment to support the department?s metabolite analysis system for early-phase PET studies.
LabLogic Systems has been chosen by the Department of Medical Physics and Clinical Engineering at Addenbroke's Hospital in Cambridge, UK to supply the equipment to support the department’s metabolite analysis system for early-phase PET studies.
According to a statement from Professor Peter Jarritt, the hospital’s clinical director of medical physics and clinical engineering, what stood out about the company was that "they were able to offer a comprehensive service bringing together all the key components we needed. As well as the hardware and software, they provided the expertise in qualification and validation for a GLP environment and coordinated all aspects of the project - installation, training and follow-up."
The company will be supplying a radio-HPLC detector, a HPLC system from Agilent and a well counter, sourced by the company and controlled by its radio chromatography software.
The company’s radio-HPLC detector has been developed specifically for the low-level Beta-counting necessary for studying the metabolism of novel PET radio-pharmaceuticals.
For more on the company visit www.lablogic.com
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.
